Table 1.
Subject Characteristics
| Prostate Survivors N=112 |
Breast Survivors N=213 |
Total N=325 |
|
|---|---|---|---|
| * PAM (1–4) | 3.25 (0.38) | 3.34 (0.37) | 3.31 (0.38) |
| * Age (years) | 70.0 (8.3) | 61.2 (10.7) | 64.2 (10.8) |
| * BMI (kg/m2) | 28.1 (4.2) | 28.4 (6.5) | 28.3 (5.8) |
| * Years Post Cancer Diagnosis | 6.43 (2.99) | 8.37 (4.64) | 7.76 (4.29) |
| Race | |||
| White/Caucasian | 79 (70.5%) | 170 (79.8%) | 249 (76.6%) |
| Black/African American | 18 (16.1%) | 31 (14.6%) | 49 (15.1%) |
| Other | 15 (13.4%) | 12 (5.6%) | 27 (8.3%) |
| Marital Status | |||
| Unmarried | 23 (20.7%) | 71 (33.5%) | 94 (29.1%) |
| Married | 88 (79.3%) | 141 (66.5%) | 229 (70.9%) |
| Education Level | |||
| High School | 36 (34.0%) | 52 (24.6%) | 88 (27.8%) |
| Some College | 24 (22.6%) | 70 (33.2%) | 94 (29.7%) |
| 4-Year Degree | 30 (28.3%) | 50 (23.7%) | 80 (25.2%) |
| Masters/Graduate School | 16 (15.1%) | 39 (18.5%) | 55 (17.3%) |
| Employment Status | |||
| Full-time | 21 (18.9%) | 76 (35.7%) | 97 (29.9%) |
| Part-time | 8 (7.2%) | 25 (11.7%) | 33 (10.2%) |
| Not Employed | 17 (15.3%) | 35 (16.4%) | 52 (16.1%) |
| Retired | 65 (58.6%) | 77 (36.2%) | 142 (43.8%) |
| Currently Insured | |||
| No | 11 (9.9%) | 2 (0.9%) | 13 (4.0%) |
| Yes | 100 (90.1%) | 211 (99.1%) | 311 (96.0%) |
| Current Household Income | |||
| < $20,000 | 25 (23.4%) | 19 (9.5%) | 44 (14.3%) |
| $20,000 – $59,000 | 36 (33.6%) | 59 (29.5%) | 95 (31.0%) |
| $60,000+ | 46 (43.0%) | 122 (61.0%) | 168 (54.7%) |
| Recurrence/Second Cancer | |||
| No | 100 (90.9%) | 193 (90.6%) | 293 (90.7%) |
| Yes | 10 (9.1%) | 20 (9.4%) | 30 (9.3%) |
| Years Since Last Treatment | |||
| < 2 | 11 (10.4%) | 9 (4.3%) | 20 (6.3%) |
| 2–5 | 56 (52.8%) | 111 (52.6%) | 167 (52.7%) |
| 6 – 10 | 33 (31.1%) | 62 (29.4%) | 95 (30.0%) |
| 10 + | 6 (5.7%) | 29 (13.7%) | 35 (11.0%) |
| Number of Comorbidities | |||
| 0 – 2 | 60 (53.6%) | 121 (56.8%) | 181 (55.7%) |
| 3 + | 52 (46.4%) | 92 (43.2%) | 144 (44.3%) |
| ~ Doctors Used for Cancer Follow-up (Last 2 Yrs.) | |||
| PCP | 41 (36.6%) | 59 (27.7%) | 100 (30.8%) |
| Cancer Specialist/Oncologist | 90 (80.4%) | 200 (93.9%) | 290 (90.1%) |
| Obstetrician/Gynecologist | N/A | 71 (33.3%) | 71 (22.4%) |
| Ideal Cancer-related Follow-up | |||
| PCP | 19 (18.1%) | 6 (2.8%) | 25 (7.9%) |
| Cancer Specialist/Oncologist | 85 (81.0%) | 205 (96.7%) | 290 (91.5%) |
| Other | 1 (0.9%) | 1 (0.5%) | 2 (0.6%) |
| Uncertainty About Future | |||
| Almost Never | 29 (26.9%) | 44 (20.7%) | 73 (22.8%) |
| Not Very Much | 28 (25.9%) | 53 (25.0%) | 81 (25.3%) |
| Sometimes | 39 (36.1%) | 82 (38.7%) | 121 (37.8%) |
| Very Often | 12 (11.1%) | 33 (15.6%) | 45 (14.1%) |
| Fear of Cancer Recurrence | |||
| Almost Never | 24 (22.0%) | 15 (7.2%) | 39 (12.3%) |
| Not Very Much | 28 (25.7%) | 29 (13.9%) | 57 (17.9%) |
| Sometimes | 40 (36.7%) | 106 (50.7%) | 146 (45.9%) |
| Very Often | 17 (15.6%) | 59 (28.2%) | 76 (23.9%) |
| Easy Access to Medical Care | |||
| PCPs | |||
| Disagree/Uncertain | 13 (12.4%) | 14 (6.9%) | 27 (8.8%) |
| Agree | 70 (66.6%) | 104 (51.5%) | 174 (56.7%) |
| Strongly Agree | 22 (21.0%) | 84 (41.6%) | 106 (34.5%) |
| Cancer-Related Clinician(s) | |||
| Disagree/Uncertain | 13 (15.5%) | 10 (4.9%) | 23 (8.0%) |
| Agree | 51 (60.7%) | 103 (50.8%) | 154 (53.7%) |
| Strongly Agree | 20 (23.8%) | 90 (44.3%) | 110 (38.3%) |
| Doctors Spend Enough Time | |||
| PCPs | |||
| Disagree/Uncertain | 22 (21.4%) | 41 (20.3%) | 63 (20.6%) |
| Agree | 60 (58.2%) | 104 (51.5%) | 164 (53.8%) |
| Strongly Agree | 21 (20.4%) | 57 (28.2%) | 78 (25.6%) |
| Cancer-Related Clinician(s) | |||
| Disagree/Uncertain | 18 (21.2%) | 32 (15.7%) | 50 (17.3%) |
| Agree | 44 (51.7%) | 97 (47.5%) | 141 (48.8%) |
| Strongly Agree | 23 (27.1%) | 75 (36.8%) | 98 (33.9%) |
Data presented as n (%) unless otherwise indicated.
*
Data presented as mean (SD).
~
Percentages add to more than 100% because participants could select more than one option.